Archive for December, 2009

Central Kentucky Radiology Partners with AMICAS for Radiology Billing and RIS Solutions

AMICASAMICAS, Inc. has announced a new contract with Central Kentucky Radiology that will allow the latter to use AMICAS Financials(TM) to streamline their radiology billing and AMICAS RIS(TM) to gain practice management efficiencies and to further improve service delivery. Central Kentucky Radiology, a 24-radiologist practice, provides interpretation services for 14 hospitals and four imaging centers. In practice for more than 40 years, Central Kentucky Radiology provides mammography, x-ray, ultrasound, CT, MRI, and interventional radiology services.

For the full story, Click Here

Use of 3-D Imaging on Patients With Pancreatic Carcinoma

University of HeidelbergThe research team, from the University of Heidelberg, Department of Diagnostic and Interventional Radiology, found that a three-dimensional image of the pancreas represents an additional, valuable aid to the surgeon in the preoperative assessment of the resection of a pancreatic carcinoma. They examined ten patients with suspected pancreatic tumors prospectively using multidetector CT. Using the CT data sets, a three-dimensional image was created.

For the full story, Click Here

Radiologists Rap Study Linking CT Scans with Cancer

American College of RadiologyThe American College of Radiology has challenged the validity of two studies published this week in the Archives of Internal Medicine that link the overuse of CT scans with thousands of new cancer diagnoses and deaths. At the same time, ACR acknowledged that widespread CT scan use has resulted in increased radiation exposure for Americans, and called for greater oversight and vigilance to prevent needless overuse.

For the full story, Click Here

SciClone Announces Enrollment Completion in Phase 2 Oral Mucositis Trial of SCV-07

ScicloneSciClone Pharmaceuticals, Inc. has announced that patient enrollment is complete ahead of schedule for its phase 2 trial of SCV-07 — a small molecule synthetic peptide with immunomodulating properties — for the treatment of severe oral mucositis (OM) in patients with head and neck cancer. Topline results of the oral mucositis trial are expected to be announced in the first half of 2010.

Buffalo Medical adds radiation unit

Buffalo Medical GroupBuffalo Medical Group has implemented an all-digital radiation treatment system. The group has acquired an Elektra Synergy system with image-guided radiotherapy to enable physicians to more precisely and rapidly target tumors during radiation therapy. The system uses a suite of imaging tools to give clinicians 3-D patient images. Installed at BMG’s offices on Essjay Road in Williamsville, treatments on patients began in early November.